Balderama, Baby Boy .

HRN: 25-57-59  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2024
AMPICILLIN 250MG (VIAL)
07/30/2024
08/06/2024
IV
90mg
Q 12
T/C Neonatal Sepsis
Waiting Final Action 
07/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/30/2024
08/06/2024
IV
14mg
Q 36 Hours
T/C Neonatal Sepsis
Waiting Final Action 
08/02/2024
CEFOTAXIME 500MG (VIAL)
08/02/2024
08/09/2024
IV
50mg
Q12h
PSNB
Waiting Final Action 
08/02/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/02/2024
08/09/2024
IV
7mg
Q12h
PSNB
Waiting Final Action 
08/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/02/2024
08/09/2024
IV
7mg
Q24h
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: